Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from Oxford’s Department of Paediatrics have discovered that infection can increase a baby’s sensitivity to pain, which may last longer than the infection.

Adult holding an infant's hand © Shutterstock

In a new study published in Nature Communications, researchers observed 65 newborn babies who had received a standard heel-prick blood test to look for signs of potential infection. When a baby’s blood test result suggested they may have an infection, which required further antibiotic treatment, the researchers continued to look for signs of pain or discomfort.

They found that babies with laboratory markers of inflammation associated with infection (raised C-Reactive Protein, (CRP) levels in blood) displayed more sensitivity to pain. This was measured by recording changes in each baby’s brain activity, leg reflex withdrawal activity, facial expression and heart rate in response to a clinically-required heel prick blood test.

These babies were also more sensitive to touch, which is consistent with clinical reports that infections can make babies more irritable. While behavioural signs of pain, such as facial grimacing, did not appear to be exaggerated by the presence of inflammation, this may be because fighting an infection can cause babies to be more lethargic and fatigued.

Read the full story on the University of Oxford website. 

Similar stories

Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

Sensory Supermarket event helps businesses make public-facing spaces more inclusive for autistic people

Researchers from the Universities of Oxford and Reading – in collaboration with awareness-raising organisation Sensory Spectacle – are hosting an innovative event called Sensory Supermarket as part of the Sensory Street research project.

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Tackling suicide risk in people with mental disorders

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Environmental impact of 57,000 multi-ingredient processed foods revealed

A study estimating the environmental impact of 57,000 food products in the UK and Ireland has been published by an Oxford-led research team in the journal PNAS.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.